Acute erythroleukemia with der(1;7)(q10;p10) as a sole acquired abnormality after treatment with azathioprine

Cancer Genet Cytogenet. 2008 Oct;186(1):58-60. doi: 10.1016/j.cancergencyto.2008.06.003.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Azathioprine / administration & dosage
  • Azathioprine / adverse effects*
  • Azathioprine / therapeutic use
  • Bone Marrow / pathology
  • Chromosomes, Human, Pair 1 / genetics
  • Chromosomes, Human, Pair 1 / ultrastructure*
  • Chromosomes, Human, Pair 7 / genetics
  • Chromosomes, Human, Pair 7 / ultrastructure*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Fatal Outcome
  • Female
  • Humans
  • Hypereosinophilic Syndrome / drug therapy*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Leukemia, Erythroblastic, Acute / chemically induced*
  • Leukemia, Erythroblastic, Acute / drug therapy
  • Middle Aged
  • Neutropenia / etiology
  • Shock, Septic / etiology

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine